These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27059620)

  • 1. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
    Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
    Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
    Shahrouki P; Moriarty JM; Khan SN; Bista B; Kee ST; DeRubertis BG; Yoshida T; Nguyen KL; Finn JP
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):17. PubMed ID: 30853026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
    Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
    Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.
    Shahrouki P; Khan SN; Yoshida T; Iskander PJ; Ghahremani S; Finn JP
    Pediatr Radiol; 2022 Mar; 52(3):501-512. PubMed ID: 34936018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort.
    Nayak AB; Luhar A; Hanudel M; Gales B; Hall TR; Finn JP; Salusky IB; Zaritsky J
    Pediatr Nephrol; 2015 Mar; 30(3):515-21. PubMed ID: 25212105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.
    Mukundan S; Steigner ML; Hsiao LL; Malek SK; Tullius SG; Chin MS; Siedlecki AM
    Am J Kidney Dis; 2016 Jun; 67(6):984-8. PubMed ID: 26786296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease.
    Stoumpos S; Hennessy M; Vesey AT; Radjenovic A; Kasthuri R; Kingsmore DB; Mark PB; Roditi G
    Eur Radiol; 2019 Jul; 29(7):3543-3552. PubMed ID: 30919067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferumoxytol-enhanced magnetic resonance angiography is a feasible method for the clinical evaluation of lower extremity arterial disease.
    Walker JP; Nosova E; Sigovan M; Rapp J; Grenon MS; Owens CD; Gasper WJ; Saloner DA
    Ann Vasc Surg; 2015 Jan; 29(1):63-8. PubMed ID: 25269682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults.
    Ning P; Zucker EJ; Wong P; Vasanawala SS
    Magn Reson Imaging; 2016 Feb; 34(2):152-8. PubMed ID: 26518061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.
    Stoumpos S; Hennessy M; Vesey AT; Radjenovic A; Kasthuri R; Kingsmore DB; Mark PB; Roditi G
    Eur Radiol; 2018 Jan; 28(1):115-123. PubMed ID: 28677065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced MR lymphangiography: feasibility of using ferumoxytol in patients with chronic kidney disease.
    Yekeler E; Krishnamurthy G; Smith CL; Escobar FA; Pinto E; Rapp JB; Otero HJ; White AM; Dori Y; Biko DM
    Eur Radiol; 2022 Apr; 32(4):2564-2571. PubMed ID: 35001156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferumoxytol-Enhanced MRI in Children and Young Adults: State of the Art.
    Adams LC; Jayapal P; Ramasamy SK; Morakote W; Yeom K; Baratto L; Daldrup-Link HE
    AJR Am J Roentgenol; 2023 Apr; 220(4):590-603. PubMed ID: 36197052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.
    Muehe AM; Feng D; von Eyben R; Luna-Fineman S; Link MP; Muthig T; Huddleston AE; Neuwelt EA; Daldrup-Link HE
    Invest Radiol; 2016 Apr; 51(4):221-227. PubMed ID: 26656202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular MRI with ferumoxytol.
    Finn JP; Nguyen KL; Han F; Zhou Z; Salusky I; Ayad I; Hu P
    Clin Radiol; 2016 Aug; 71(8):796-806. PubMed ID: 27221526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
    Neuwelt EA; Hamilton BE; Varallyay CG; Rooney WR; Edelman RD; Jacobs PM; Watnick SG
    Kidney Int; 2009 Mar; 75(5):465-74. PubMed ID: 18843256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
    Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
    Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct contrast-enhanced 3D MR venography evaluation of upper extremity deep venous system.
    Tanju S; Sancak T; Düşünceli E; Yağmurlu B; Erden I; Sanlidilek U
    Diagn Interv Radiol; 2006 Jun; 12(2):74-9. PubMed ID: 16752353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.
    Nguyen KL; Park EA; Yoshida T; Hu P; Finn JP
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):106. PubMed ID: 29284494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts.
    Shah A; Neitzel E; Panda A; Fananapazir G
    Abdom Radiol (NY); 2024 Aug; 49(8):2858-2872. PubMed ID: 38561553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
    Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
    Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.